Prophylaxis against post-spinal hypotension in elective C-section: Efficacy of Norepinephrine

Published On: 22 Feb, 2024 12:53 PM | Updated On: 20 May, 2024 8:53 AM

Prophylaxis against post-spinal hypotension in elective C-section: Efficacy of Norepinephrine

The objective of a study was to compare the effectiveness and safety of norepinephrine (NE) and phenylephrine (PE) infusions in preventing post-spinal hypotension during cesarean section (C-section) under spinal anesthesia (SA).

This was a randomized clinical trial that enrolled 164 ASA I and II parturients undergoing C-sections under SA. All participants were prophylactically administered NE (0.05 µg/kg/min) or PE (0.75µg/kg/min) infusions. The primary outcome was the incidence of post-spinal hypotension. Secondary outcomes included severe post-spinal hypotension, reactive hypertension, bradycardia, total vasopressor rescue doses, physician interventions, nausea and vomiting, and Apgar scores at 1 and 5 minutes.

The results indicated comparable incidences of post-spinal hypotension and severe post-spinal hypotension between NE and PE groups. The need for vasopressor rescue doses, incidence of bradycardia, and reactive hypertension were similar in both groups. Meanwhile, nausea and vomiting were low and comparable. However, the number of physician interventions was significantly higher in the PE group (39.02%) compared to the NE group (28.04%).

The findings showed that the hemodynamics were comparable with NE and PE infusions in preventing hypotension during elective C-section; NE was associated with a lower number of physician interventions compared to PE. The study suggests that NE may be a preferable option for preventing post-spinal hypotension in patients undergoing an elective C-section.

Source: Saharia HK, Barman RK, Mili T, Sarma A, Barman M, Saikia B, Rajbongshi A. The New Indian Journal of OBGYN. 2023; 10(1): 46-53.

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks